Imaging Biometrics Ltd.
IQAIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.24 | -0.62 | 1.82 | 0.51 |
| FCF Yield | -12.78% | -2.64% | -13.08% | -3.19% |
| EV / EBITDA | -12.56 | -13.05 | -8.10 | -28.44 |
| Quality | ||||
| ROIC | -108.26% | -428.05% | -70.84% | -39.35% |
| Gross Margin | 98.96% | 98.09% | 99.67% | 96.73% |
| Cash Conversion Ratio | 0.42 | 0.16 | 0.73 | 0.58 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.86% | 5.36% | 28.04% | 24.83% |
| Free Cash Flow Growth | -154.03% | 57.73% | -20.06% | 24.08% |
| Safety | ||||
| Net Debt / EBITDA | 0.20 | 0.28 | 0.70 | 1.89 |
| Interest Coverage | 0.00 | -41.19 | -46.77 | -45.78 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 80.35 | 83.91 | 0.00 | 34.71 |